Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
disease | 0.600 | strong | 1.000 | 3 | 7 | 2012 | 2017 | ||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2012 | 2017 | ||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
RAB33B, member RAS oncogene family | 0.821 | 0.192 | 0.68 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 |